Portfolio company
Hillstar Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HI-Bio
This biotechnology company develops targeted therapies for patients suffering from severe immune-mediated diseases.
Re-Aim Therapeutics
This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.
Arda Therapeutics
This biotechnology company develops targeted cell depletion therapies to treat chronic diseases by identifying and removing specific pathogenic cells in patients.
Epana Bio
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
Rhapsogen
This biotechnology company develops precision biologic therapeutics to treat autoimmune diseases by modulating antibody effector functions for patients with inflammatory conditions.
Merida Biosciences
This company develops precision immunology therapies to treat patients suffering from autoimmune and allergic disorders.
Egle Therapeutics
This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.
Beeline Medicines
This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.
